New hope for rare, painful skin disease: experimental drug EPN-701 enters phase 2 trial
Disease control
Not yet recruiting
This study tests a new drug called EPN-701 for calciphylaxis, a rare condition causing painful skin sores with no approved treatment. About 60 adults with moderate to severe pain and at least one open sore will receive the drug. The main goals are to see if EPN-701 safely reduces…
Phase: PHASE2 • Sponsor: Sagar U. Nigwekar, MD, MMSc • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC